Bioimpedance analysis vs. DEXA as a screening tool for osteosarcopenia in lean, overweight and obese Caucasian postmenopausal females

Peppa, Μelpomeni; Stefanaki, Charikleia; Papaefstathiou, Athanasios; Boschiero, Dario; Dimitriadis, George; Chrousos, George P.

doi:10.14310/horm.2002.1732

Cited by 21 publications

(12 citation statements)

References 57 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, bone mass measurements using bioelectrical impedance are becoming more commonplace. The instrument used to detect OSO in a young population [28], BIA-ACC ® (BioTekna srl, Marcon-Venice, Italy), includes bone mass (kg; whole body) as well as other body composition parameters and has been developed and validated against DXA [48]. This instrument gives the total quantity of bone in the body but cannot distinguish among different skeletal sites like DXA.…”

Section: Persisting Difficulties In the Identification Of Oso And mentioning

confidence: 99%

“…Measuring bone parameters using BIA is no longer the exception, probably due to its convenience. BIA-ACC ® (BioTekna ® , Marcon-Venice, Italy) was recently validated against DXA [48] for the determination of total bone mass (kg). However, while this instrument is versatile in relation to OSO, it provides whole body bone mass and a T-score, it cannot distinguish among different skeletal sites.…”

Section: Future Refinements For Oso Diagnosis and Treatmentmentioning

confidence: 99%

“…BIA-ACC ® assesses quantitative and qualitative body composition data and contains information on total body water, extracellular and intracellular water, fat mass and fat free mass (kg and % body weight), total bone mass (kg) and T-score, skeletal muscle mass (kg and % fat free mass) and S-score as well as IMAT. BIA-ACC ® was validated against DXA in postmenopausal women of varied weight and body composition [48]. PPG-StressFlow ® provides analyses, monitoring and biofeedback of the autonomic nervous system and heart rate and providing information on chronic stress, systemic inflammation, oxidative stress and insulin resistance [27,116].…”

Section: Future Refinements For Oso Diagnosis and Treatmentmentioning

confidence: 99%

See 2 more Smart Citations

Osteosarcopenic Obesity: Current Knowledge, Revised Identification Criteria and Treatment Principles

Kelly

Gilman

Boschiero³

et al. 2019

Nutrients

View full text Add to dashboard Cite

Osteosarcopenic obesity (OSO) syndrome describes the simultaneous deterioration of bone, muscle and excess fat, resulting in reduced functionality and systemic metabolic dysregulation. The key component contributing to this may be ectopic fat in the viscera, bone and muscle. OSO research to date is summarized, and the revised criteria for its identification for research purposes are reviewed and proposed, including new criteria to assess visceral fat in males and females. Finally, nutritional and physical activity recommendations are consolidated into a treatment algorithm, which can be validated in future studies and which may also be applied to preventative management.

show abstract

Section: Persisting Difficulties In the Identification Of Oso And mentioning

confidence: 99%

Section: Future Refinements For Oso Diagnosis and Treatmentmentioning

confidence: 99%

Section: Future Refinements For Oso Diagnosis and Treatmentmentioning

confidence: 99%

See 1 more Smart Citation

Osteosarcopenic Obesity: Current Knowledge, Revised Identification Criteria and Treatment Principles

Kelly

Gilman

Boschiero³

et al. 2019

Nutrients

View full text Add to dashboard Cite

show abstract

“…The body composition bio-impedance analysis was performed with a BIA-ACC device (BIOTEKNA Biomedical Technologies) [32,33]. This device applies alternating currents using two different frequencies, 50 and 1.5 kHz [bi-frequency measurement method], to measure body composition based on a multi-compartment model (2C, 3C, 4C, 5C).…”

Section: Methodsmentioning

confidence: 99%

“…The formulas used for computations have been previously described in detail. This method is simple, rapid, does not require skilled staff and does not expose individuals to radiation [32,33]. The device has been validated against dual energy X-ray absorptiometry (DXA) [33].…”

Section: Methodsmentioning

confidence: 99%

Lean Women on Metformin and Oral Contraceptives for Polycystic Ovary Syndrome Demonstrate a Dehydrated Osteosarcopenic Phenotype: A Pilot Study

et al. 2019

View full text Add to dashboard Cite

Scarce data exist on the body composition of lean women with polycystic ovary syndrome (PCOS) on treatment with metformin and oral contraceptives (OCs). Thirty-four lean (body mass index 18.5–24.9 kg/m2) women (17 with PCOS on metformin and OCs treatment for six months and 17 controls) aged 18–40 years were assessed for body composition parameters (fat, muscle, glycogen, protein masses, bone masses, and body water compartments) and phase angles. PCOS patients demonstrated lower muscle, glycogen and protein masses (U = 60, p = 0.003), along with a lower bone mineral content and mass (U = 78, p = 0.021; U = 74, p = 0.014) than their healthy counterparts, while total and abdominal fat masses were similar between the two groups. PCOS patients also exhibited increased extracellular body water (U = 10, p < 0.001) and decreased intracellular water, compatible with low-grade inflammation and cellular dehydration. Key differences in body composition between women with PCOS and controls demonstrated an osteosarcopenic body composition phenotype in PCOS patients. A confirmation of these findings in larger studies may render osteosarcopenia management a targeted adjunct therapy in women with PCOS.

show abstract

Cross‐sectional study of patients with VCP multisystem proteinopathy 1 using dual‐energy x‐ray absorptiometry

Columbres,

Luu,

Nguyen

et al. 2024

Muscle and Nerve

View full text Add to dashboard Cite

Introduction/AimsVCP multisystem proteinopathy 1 (MSP1), encompassing inclusion body myopathy (IBM), Paget's disease of bone (PDB) and frontotemporal dementia (FTD) (IBMPFD), features progressive muscle weakness, fatty infiltration, and disorganized bone structure in Pagetic bones. The aim of this study is to utilize dual‐energy x‐ray absorptiometry (DXA) parameters to examine it as a biomarker of muscle and bone disease in MSP1.MethodsDXA scans were obtained in 28 patients to assess body composition parameters (bone mineral density [BMD], T‐score, total fat, and lean mass) across different groups: total VCP disease (n = 19), including myopathy without Paget's (“myopathy”; n = 12) and myopathy with Paget's (“Paget”; n = 7), and unaffected first‐degree relatives serving as controls (n = 6).ResultsIn the VCP disease group, significant declines in left hip BMD and Z‐scores were noted versus the control group (p ≤ .03). The VCP disease group showed decreased whole body lean mass % (p = .04), and increased total body fat % (p = .04) compared to controls. Subgroup comparisons indicated osteopenia in 33.3% and osteoporosis in 8.3% of the myopathy group, with 14.3% exhibiting osteopenia in the Paget group. Moreover, the Paget group displayed higher lumbar L1‐L4 T‐score values than the myopathy group.DiscussionIn MSP1, DXA revealed reduced bone and lean mass, and increased fat mass. These DXA insights could aid in monitoring disease progression of muscle loss and secondary osteopenia/osteoporosis in MSP1, providing value both clinically and in clinical research.

show abstract

Bioimpedance analysis vs. DEXA as a screening tool for osteosarcopenia in lean, overweight and obese Caucasian postmenopausal females

Abstract: ® is a rapid, bloodless and useful screening tool for determining body composition, adiposity and presence of osteo- HORMONES 2017, 16(2):181-193

Cited by 21 publications

References 57 publications

Osteosarcopenic Obesity: Current Knowledge, Revised Identification Criteria and Treatment Principles

Osteosarcopenic Obesity: Current Knowledge, Revised Identification Criteria and Treatment Principles

Lean Women on Metformin and Oral Contraceptives for Polycystic Ovary Syndrome Demonstrate a Dehydrated Osteosarcopenic Phenotype: A Pilot Study

Cross‐sectional study of patients with VCP multisystem proteinopathy 1 using dual‐energy x‐ray absorptiometry

Contact Info

Product

Resources

About